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Abstract
Background Direct healthcare costs of patients with
symptomatic diverticular disease randomized for either lap-
aroscopic or open elective sigmoid resection are compared.
Cost-effectiveness analysis of the laparoscopic approach
compared with open sigmoid resections is presented.
Methods An economic evaluation of the randomized
control Sigma trial was conducted, comparing elective
laparoscopic sigmoid resection (LSR) to open sigmoid
resection (OSR) in patients with symptomatic diverticulitis.
Prospective registration of detailed intervention units per
patient resulted in actual resource use per individual
patient. To avoid distributional assumptions, the nonpara-
metric bootstrap was applied. For the cost-effectiveness
analysis, differences in total cost between LSR and OSR
were compared with the differences in VAS pain score, SF-
36 values for general health, and complication rate.
Results The difference in total healthcare costs between
the group that received LSR (€ 9969) and the group that
received OSR (€ 9366) was not statistically significant. The
slight increase in total costs was determined mainly by the
significantly higher operation costs of LSR (€ 6663 vs.
€ 5306). Lower costs for hospitalization (€ 2983 vs. € 3598),
blood products (€ 87 vs. € 240), paramedical services (€ 157
vs. € 278), and emergency attendance (€ 72 vs. € 115) in the
LSR group partially compensated these increased operation
costs. The incremental cost-effectiveness ratios (ICER)
indicate that improvements in pain, quality of life, and
complication rate could be achieved at limited costs.
Conclusion Total healthcare costs of laparoscopic and
open elective sigmoid resections for symptomatic diver-
ticular disease are similar. As the clinical outcomes are in
favor of the LSR group, candidates for an elective sigmoid
resection should preferably be approached laparoscopically.
Keywords Diverticulitis  Diverticular disease 
Laparoscopy  Cost analysis
Diverticular disease is one of the major gastrointestinal
disorders in the Western society, with an incidence rate of
33% in the population over 45 years of age and 66% in the
population older than 85 years of age [1]. Approximately
10-25% of patients with asymptomatic diverticulosis will
develop acute diverticulitis [2]. Each year diverticular
disease accounts for 312,000 hospital admissions in the
United States, costing a total of $2,667,000,000 [3, 4].
The treatment of diverticular disease depends on the
severity of the disease, varying from light symptomatic
diverticulosis to perforated diverticulitis [5]. An elective
sigmoid resection is indicated in complicated cases such as
stricture of the sigmoid colon, a fistula to a hollow organ,
or recurrent diverticular bleeding [6, 7]. Other indications
like recurrent episodes or persistent complaints in young
patients and certain high-risk groups (i.e., immunocom-
promised or users of NSAIDs) remain controversial [8, 9].
Over the past two decades the laparoscopic approach in
the management of diverticular disease has gained accep-
tance. Several nonrandomized comparison studies showed
beneficial outcomes of laparoscopic sigmoid resection,
such as shorter hospitalization and a reduction in postop-
erative complication rates [10–12]. The reported Sigma
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trial was the first randomized control trial to compare
laparoscopic versus open elective sigmoid resections in
patients with symptomatic diverticular disease [13]. The
short-term results showed that the laparoscopic approach
was associated with a significant 15.4% reduction in major
complication rate, less pain, shorter hospitalization, and
improved quality of life at the cost of a longer operating
time [14]. Despite these short-term benefits, comparable
outcomes were found at 6 months follow-up in terms of
late complications, mortality, and quality of life.
In contrast, concerns remain regarding the higher
healthcare costs associated with laparoscopic colorectal
surgery because of the longer operative procedures and the
greater use of disposable products. Studies comparing the
costs of laparoscopic and open colorectal surgery for var-
ious benign or malignant indications report conflicting
results [15]. When diverticular disease is considered, only
three nonrandomized cohort studies could be identified
[16–18]. In this article, the direct healthcare costs of
patients with symptomatic diverticular disease randomized
for either laparoscopic or open elective sigmoid resection
are compared. Furthermore, a cost-effectiveness analysis of
the laparoscopic approach compared with open sigmoid
resections is presented.
Methods
Study design
An economic evaluation of the Sigma trial was conducted
comparing elective laparoscopic sigmoid resection (LSR)
to open sigmoid resection (OSR) in patients with symp-
tomatic diverticulitis of the sigmoid colon. The Sigma trial
was a prospective, multicenter, double-blind, parallel-arm,
randomized control study. Eligible patients were random-
ized to either LSR or OSR. The cost effectiveness was
investigated for patients included in the VU University
Medical Center.
End points included postoperative mortality, and compli-
cations were classified as minor, major, and late. Secondary
outcome measures included operating time, estimated blood
loss, conversion rate, hospital stay, usage of analgesia, Visual
Analog Scale (VAS) pain score, resumption of diet, and
quality of life assessment by the Short Form-36 (SF-36)
questionnaire.
Written informed consent was obtained from eligible
patients. The generator of the allocation sequence was
separated from the executor. Blinding was ensured by
using an opaque wound dressing to cover the abdomen.
Symptomatic diverticulitis of the sigmoid colon was
defined as recurrent disease Hinchey I, IIa, IIb, symptom-
atic stricture, or severe rectal bleeding. The decision to
discharge patients was made by independent physicians
blind to the allocation sequence. Patients visited the out-
patient clinic 6 weeks and 6 months after surgery.
The study was conducted in accordance to the principles
of the Declaration of Helsinki and ‘‘good clinical practice’’
guidelines. The study protocol was approved by the Insti-
tutional Review Boards of all participating institutions.
Data were analyzed according to the intention-to-treat
principle. Methodological and operative details can be
found in the published protocol [13]. Study end points,
secondary outcome measures, and their assessment are
described in the clinical paper [14].
Economic evaluation
The economic evaluation was conducted from a hospital
perspective. As such, only direct healthcare costs were
considered. The study was carried out from February 2002
to December 2006. Therefore, all costs were converted to
fiscal year 2005 euros.
Since no uniformity or transparency exists for cost
registration in the different participating clinics and coun-
tries, only patients who were treated in the VU University
Medical Center were included. Data on resource use were
aggregated from the TOREN software program (iSOFT,
Leiden, The Netherlands). This program enables prospec-
tive registration of detailed intervention units per patient,
such as materials (sutures and disposables), medical
equipment, personnel costs, and specialist fees. Parameters
such as operations, admission days, or diagnostic tools are
composed of several intervention units resulting in actual
resource use per individual patient. Different parameters
are grouped into nine of categories as shown in Table 1.
The translation of resource utilization into costs was
provided by the TRAG PI software program (TRAG Per-
formance Intelligence, Zeist, The Netherlands). This
software program provided information on direct cost per
intervention unit per patient extracted from the prospective
TOREN registry. These cost prices reflect costs of real
resource use and include overhead costs.
Actual costs per individual patient are presented in eight
categories, as well as total direct costs for the period of
30 days after surgery. For the 6-months follow-up period,
only total healthcare costs are provided.
Statistical analysis
The mean differences in costs between LSR and OSR were
computed and the 95% confidence interval (95% CI) for
this difference was calculated. Because cost data are typi-
cally skewed, confidence intervals for cost differences
cannot be estimated using conventional methods that
assume normality. To avoid distributional assumptions, the
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nonparametric bootstrap was applied [19, 20]. Basically, in
the nonparametric bootstrap, samples of the same size as
the original data set are drawn by sampling with replace-
ment from the observed data. These bootstrap samples can
be used to estimate standard errors and confidence inter-
vals. To obtain 95% confidence intervals for cost differ-
ences, a nonparametric bootstrap with 2000 replications
was performed [21].
For the cost-effectiveness analysis, differences in total cost
between LSR and OSR were compared with the differences in
VAS pain scores and SF-36 values for general health. Fur-
thermore, the difference in total costs was compared to the
difference in complication rate, as this was one of the primary
end points of the study. Uncertainty around the cost-effec-
tiveness ratios was estimated using the bias-corrected and
accelerated bootstrapping method (5000 replications) and
presented on a cost-effectiveness plane [21, 22].
A sensitivity analysis was carried out to study the effect
of excluding the extreme costs incurred by one patient who
had a tenfold increase in costs of hospitalization due to a
severely complicated course at 6 months follow-up.
Results
Clinical outcomes
At baseline, no differences in clinical characteristics were
found between LSR and OSR. Short-term analysis showed
that LSR was associated with a 15.4% reduction in major
complication rate, less pain, shorter hospitalization, and
improved quality of life at the cost of longer operating
time. Full details on the clinical outcomes are presented in
the clinical papers [13, 14].
Resource use
A total of 104 patients were included in the trial, of which
57 patients were treated at the VU University Medical
Center. Twenty-seven were randomized to the LSR group
and 30 to the OSR group. Table 2 lists a selection of the
most common healthcare resource items. Note that infre-
quently used resource items are not displayed but do con-
tribute to total costs.
LSR was associated with less hospitalization, para-
medical services, and emergency attendance, but increased
use of disposable materials, imaging modalities, and
operative time. Except for operative time, differences were
small and not statistically significant.
Table 1 Resources per
category extracted from the
TRAG PI software program
Category Recourse examples
Hospitalization Admission days, laboratory testing, medication, nurses’ fee
Operation Operating room per hour, sterilization costs, disposable
materials, specialists’ fee
Imaging CT scan, ultrasound, radiograph, barium enema
Diagnostic procedures Colonoscopy, EKG
Blood products Packed cells, fresh frozen plasma
Consulting specialists Cardiology, Internal Medicine, Dermatology
Paramedical services Physiotherapy, dietician, stoma care, social worker
Emergency and outpatient attendance Follow-up and/or emergency visits for complications
Table 2 Mean (SD) resource utilization per treatment group within
30 days
LSR n OSR n
Hospital stay (days) 8.41 (4.81) 27 9.30 (4.66) 30
Operative time (min)* 211.73 (33.52) 27 145.59 (40.87) 30
Imaging
CT abdomen 0.22 (0.97) 3 0.07 (0.25) 2
Abdominal ultrasound 0.07 (0.27) 2 0 0
Chest or abdominal X-ray 0.67 (1.07) 11 0.70 (1.06) 15
Barium enema 0.07 (0.27) 2 0.07 (0.25) 2
Diagnostic procedures
Colonoscopy 0 0 0.10 (0.55) 1
EKG 0.41 (0.69) 9 0.27 (0.58) 6
Laboratory
Laboratory tests 11.44 (14.38) 24 11.23 (14.63) 29
Blood products 0.37 (0.97) 4 1.23 (2.71) 8
Consulting specialists (visits)
Internal Medicine 0.15 (0.46) 3 0.13 (0.35) 4
Cardiology 0.11 (0.32) 3 0.10 (0.31) 3
Paramedical services (visits)
Physiotherapy 0.56 (1.28) 8 2.20 (3.86) 10
Dietician 0.44 (1.31) 4 0.57 (2.75) 2
Stoma-care 1.00 (2.92) 3 1.77 (3.57) 7
Emergency and outpatient attendance (visits)
Follow-up 1.56 (0.75) 27 1.33 (1.09) 23
Emergency 0.07 (0.27) 2 0.13 (0.43) 3
n columns indicate the number of patients with resource use
* p = 0.000; no other significant differences
778 Surg Endosc (2011) 25:776–783
123
Costs
Table 3 shows the mean costs for the two groups per cate-
gory. Total healthcare costs within 30 days were € 9969 for
LSR and € 9366 for OSR. Compared with OSR, this was a
6.4% (€ 603) increase in total healthcare costs within 30 days
for LSR, which was not statistically significant (95%
CI = -957 to 2162). These costs were determined mainly
by the significantly higher operation cost of € 6663 for LSR
vs. € 5306 for OSR. These increased costs were partially
compensated for by lower costs for hospitalization (LSR
€ 2983 vs. OSR € 3598), blood products (LSR € 87 vs. OSR
€ 240), paramedical services (LSR € 157 vs. OSR € 278), and
emergency attendance (LSR € 72 vs. OSR € 115). These
latter differences, however, were not significant.
Total costs at 6 months follow-up were € 17,203 for
LSR and € 11,357 for OSR (difference = € 5846; 95%
CI = -6105 to 17,797) (see Table 4). A substantial
increase in total costs at 6 months follow-up was found in
the LSR group, which was solely determined by a very
complicated course for one patient. This patient underwent
a Hartmann’s procedure for a large intra-abdominal
abscess, followed by anastomotic leakage when restoration
of bowel continuity was attempted. Major contributors to
the enormous costs were prolonged stay in the intensive
care unit, blood products, a total of nine reoperations and
23 CT scans. When excluding this single patient in a
sensitivity analysis, total costs at 6 months were € 11,344
for LSR and € 11,357 for OSR (difference = € 12; 95%
CI = -3438 to 3499).
Cost effectiveness
Table 4 shows the total costs and effects within 30 days
and at 6 months follow-up for the different outcome
measures. Table 5 shows the differences in total costs and
Table 3 Mean (SD) costs (€)
per treatment group within
30 days
a Difference with 95% CI
obtained from a nonparametric
bootstrap method with 2000
replications
LSR (n = 27) OSR (n = 30) Difference (95% CI)a
Hospitalization 2982.80 (1403.45) 3597.71 (1850.73) -614.69 (-1500.83 to 248.17)
Operation 6662.80 (1402.67) 5306.21 (1480.59) 1356.57 (319.18 to 2156.52)
Imaging 100.04 (186.67) 86.39 (140.93) 13.66 (-79.98 to 94.17)
Diagnostic procedures 62.19 (128.97) 53.50 (128.16) 8.69 (-62.23 to 72.64)
Blood products 87.24 (198.78) 240.08 (528.86) -152.88 (-305.24 to 42.73)
Consulting specialists 63.01 (176.97) 47.69 (110.95) 15.32 (-70.69 to 84.29)
Paramedical services 157.32 (426.52) 278.39 (568.60) -121.07 (-277.56 to 150,72)
Emergency and
outpatient attendance
71.89 (80.27) 115.26 (135.55) -43.38 (-98.53 to 10.71)
Total costs 9969.44 (2578.00) 9366.03 (3127.18) 603.37 (-956.86 to 2161.77)
Table 4 Mean costs (€) and
effects by treatment group for
all patients
* p values for effect differences
LSR OSR p*
Costs Effects Costs Effects
VAS pain score (n = 27/30) 9969.44 3.69 9366.03 5.50 0.000
SF-36 six weeks (n = 22/24) 10,030.56 61.59 9111.25 58.18 0.499
30 days morbidity (n = 27/30) 9969.44 7.40% 9366.03 26.70% 0.056
SF-36 six months (n = 22/27) 18,891.12 60.23 11,504.12 56.98 0.588
6 months morbidity (n = 27/30) 17,202.78 14.80% 11,356.81 46.70% 0.010
Table 5 Mean cost (€) and
effect differences between
treatment groups and cost-
effectiveness ratios for all
patients
a A negative sign indicates a
decrease in pain and
complications, meaning actual
improvement in effect
LSR–OSR
Cost
difference
Effect
difference
ICER (95% CI)
VAS pain score (n = 27/30) 603.41 -1.82a 332.46 (-302.30 to 1553.26)
SF-36 six weeks (n = 22/24) 919.30 3.41 269.29 (-1905.13 to 2276.33)
30 days morbidity (n = 27/30) 603.41 -19.30%a 31.26 (-458.32 to 680.32)
SF-36 six months (n = 22/27) 7387.00 3.25 2271.53 (-21957.08 to 23502.55)
6 months morbidity (n = 27/30) 5845.97 -31.90%a 183.26 (-59.38 to 1303.27)
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effects, the incremental cost-effectiveness ratios (ICER),
and their 95% confidence intervals (95% CI).
The ICER for pain was € 332 per unit on the Visual
Analog Scale (VAS). Considering that a negative VAS
difference is an improvement, this incremental cost-effec-
tiveness ratio means that LSR costs € 332 per VAS unit
that is gained by performing LSR instead of OSR. Fig-
ure 1A shows the cost-effectiveness plane for improvement
in VAS. In total, 89% of the cost–effect pairs lie above the
X axis and right to the Y axis, the area where LSR is
associated with decreasing pain but more expenses.
The cost-effectiveness ratio for the general health score
of the Short Form-36 (SF-36) at 6 weeks was € 269 per SF-
36 unit, meaning that LSR costs € 269 per gained general
health unit. Figure 1B shows the corresponding cost-
effectiveness plane. Seventy-four percent of the cost–effect
pairs lie in the upper-right quadrant, corresponding with
increased quality of life and higher costs.
Complication rate within 30 days of surgery was asso-
ciated with a cost-effectiveness ratio of € 31, implicating a
cost of € 31 per percent decrease in complication rate.
Figure 1C shows the corresponding cost-effectiveness
plane. For 85% of the cost–effect pairs, the complication
rate was decreased at a higher cost.
The ICERs for general health score and complication
rate at 6 months follow-up are shown in Table 5. The large
95% confidence intervals illustrate the influence of the
single extremely complicated patient. To study the effect of
this outlier, a sensitivity analysis was carried out. The
exclusion of the extreme costs incurred by one severely
complicated patient resulted in an ICER for general health
of € 57 (95% CI = -2753 to 3436) and for complication
rate of -€ 0.35 (95% CI = -73 to 140). Although slightly
higher cost-effectiveness ratios were found for LSR at six
months follow-up (not significant), similar values for LSR
and OSR were found in this sensitivity analysis.
Discussion
In this study we investigated the cost effectiveness of
laparoscopic (LSR) versus open elective sigmoid resection
(OSR) for patients with symptomatic diverticular disease.
The difference in total healthcare costs between the LSR
group and the OSR group was not statistically significant.
Overall, costs for the LSR group were somewhat higher
than for the OSR group (€ 603), but this difference was
surrounded by large confidence bounds (-957 to 2162).
The increase in total costs was determined mainly by the
significantly higher operation costs of the laparoscopic
approach. Lower costs for hospitalization, blood products,
paramedical services, and emergency attendance in the
LSR group partially compensated these increased operation
costs. The effect differences between the two treatment
groups, in particular, during the first 30 days, were in favor
of LSR, with a significant decrease in pain (VAS) and
complication rate and a significant increase in quality of
life (SF-36).
The cost-effectiveness analyses showed that these
improvements in health could be achieved at limited costs
(e.g., € 31 per percentage decrease in major complication
within 30 days). As was observed for the costs, the incre-
mental cost-effectiveness ratios of LSR versus OSR were
also surrounded by large confidence bounds, including
negative ICERs indicating that there is even a small chance
that the health gain can be achieved at lower costs. Based
on these findings it can be concluded that laparoscopic and
open sigmoid resection are equivalent treatment options
with respect to costs and that a choice should thus be based
on the observed effect differences only.
An interesting finding regarding complication rates
resulted from the subgroup analysis of the VU University
Medical Center population. In the clinical paper on short-
term results of the Sigma trial, a significant 15.4% reduc-
tion in major morbidity rate for the laparoscopic approach
was presented; when analyzing those 57 VU patients, a
19.3% reduction was observed (p = 0.056). Unpublished
data on 6 months follow-up demonstrate late complication
rates of 13.5 and 23.1% for LSR and OSR, respectively
(p = 0.205). The pooling of both short-term and late
complications per patient included in the VU University
Medical Center resulted in a significant 31.9% reduction of
total complication rates at 6 months follow-up (LSR 14.8%
vs. OSR 46.7%; p = 0.010).
The main strength of this study lies in the cost-regis-
tration method. In most studies an estimation of mean costs
of interventions is made based on average resource use
[15]. In this study the resource utilization results from
prospective registration of detailed resource items per
patient. This registry therefore enables a more accurate
calculation of actual costs per individual patient.
In addition, this study is the first to relate total healthcare
costs to clinical outcome measures of laparoscopic versus
open resections in colorectal surgery. Several papers pre-
sented effects and costs side by side, but all did not conduct
cost-effectiveness analyses. Beneficial outcomes after lap-
aroscopic sigmoid resections for diverticular disease, such
as shorter hospitalization and a reduction in postoperative
complication rates, have been reported in nonrandomized
comparison studies [10–12]. In recent literature only three
papers report on a comparison of costs between laparo-
scopic and open sigmoid resections for diverticular disease
[16–18]. Although there are differences in the assessment
of resource utilization, in calculations of total costs, and in
use of statistical methods, all three studies demonstrate a
decrease in total hospital costs of 23–25%. Limited
780 Surg Endosc (2011) 25:776–783
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Fig. 1 Cost-effectiveness
planes. A Cost-effectiveness
plane for improvement in VAS
pain score for LSR vs. OSR.
B Cost-effectiveness plane for
improvement in general health
score of the SF-36 for LSR vs.
OSR. C Cost-effectiveness
plane for reduction in major
complication rate for LSR
versus OSR
Surg Endosc (2011) 25:776–783 781
123
breakdown of the costs measured make these results dif-
ficult to compare to the current study. In the current study,
cost-effectiveness ratios are presented for the VAS pain
score, the general health score of the Short Form-36, and
major complication rates, the latter being the primary end
point of the Sigma trial. Pain and quality of life were
chosen as effect measures for being the main determinants
of subjective well-being of surgical patients [23, 24].
A limitation of this study may be the selection of
patients from the VU University Medical Center. Only 57
patients of the total of 104 included in the multicenter
Sigma trial were subjected to these cost analyses. Since no
uniform or transparent cost registration exists for different
hospitals in The Netherlands, let alone for various coun-
tries, cost-effectiveness analyses in this manner could not
be performed. Moreover, problems arise in making inter-
national comparisons of costs because prices of resources
may differ between countries. Publications on resource use
and costs of laparoscopic versus open colorectal surgery
report a wide spectrum of mean costs, ranging from € 1752
[25] and € 3666 [26] to € 20,380 [27] and € 25,277 [17].
These large differences reflect the heterogeneity of costs
and their registration methods between hospitals and
countries. Nevertheless, in a systematic review article,
Dowson et al. [15] concluded that total hospital costs are
similar for laparoscopic and open colorectal surgery.
Therefore, cost should not be a deterrent to performing
laparoscopic colorectal surgery.
In conclusion, total healthcare costs of laparoscopic and
open elective sigmoid resections for symptomatic diver-
ticular disease are similar. As the differences in clinical
outcomes between the two treatment groups are in favor of
the LSR group, candidates for an elective sigmoid resection
should preferably be approached laparoscopically.
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